Howlett S A, McGuigan J E
Gastroenterology. 1975 Oct;69(4):960-4.
Macrophage migration inhibition factor produced in response to purified hepatitis Bs antigen has been demonstrated in patients with and recovering from hepatitis B antigen-positive acute viral hepatitis. These results suggest that cell-mediated immunity against this antigen occurs concomitantly with the illness, and may be important in its pathogenesis. In addition, patients with chronic aggressive hepatitis, whether serologically positive or negative for hepatitis Bs antigen, were also found to have positive macrophage migration inhibition tests. This observation suggests a role for hepatitis B virus in the majority of patients with chronic aggressive hepatitis. Negative macrophage migration inhibition tests in response to the antigen were noted in acute viral hepatitis seronegative for the hepatitis B antigen, alcoholic hepatitis, normal controls, and carriers of the antigen.
在乙肝表面抗原阳性的急性病毒性肝炎患者以及正在康复的此类患者中,已证实存在针对纯化乙肝表面抗原产生的巨噬细胞移动抑制因子。这些结果表明,针对该抗原的细胞介导免疫与疾病同时发生,并且可能在其发病机制中起重要作用。此外,还发现慢性活动性肝炎患者,无论乙肝表面抗原血清学检测呈阳性还是阴性,巨噬细胞移动抑制试验均为阳性。这一观察结果提示乙肝病毒在大多数慢性活动性肝炎患者中发挥作用。在乙肝表面抗原血清学检测呈阴性的急性病毒性肝炎患者、酒精性肝炎患者、正常对照者以及该抗原携带者中,针对该抗原的巨噬细胞移动抑制试验结果为阴性。